Rankings
▼
Calendar
CRBU Q3 2023 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CRBU
Caribou Biosciences, Inc.
$186M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$24M
+616.4% YoY
Gross Profit
-$5M
-20.8% margin
Operating Income
-$15M
-61.8% margin
Net Income
-$10M
-42.3% margin
EPS (Diluted)
$-0.12
QoQ Revenue Growth
+530.1%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$34M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$458M
Total Liabilities
$59M
Stockholders' Equity
$398M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$24M
$3M
+616.4%
Gross Profit
-$5M
$3M
-249.0%
Operating Income
-$15M
-$27M
+44.9%
Net Income
-$10M
-$27M
+62.5%
Geographic Segments
UNITED STATES
$23M
98%
Non-US
$377,000
2%
← FY 2023
All Quarters
Q4 2023 →